Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | MEDISTEP Medistep Healthcare Ltd. Pharma · SME | MADHAVBAUG Vaidya Sane Ayurved Laboratories Ltd. Pharma · SME | NEPHROCARE Nephro Care India Ltd. Pharma · SME | MAITREYA Maitreya Medicare Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 69 | 46 | 17 | 16 |
| Verdict | UNDERVALUED | FAIR VALUE | OVERVALUED | OVERVALUED |
| Style | Deep Value | Financial Turnaround | OVERVALUED | OVERVALUED |
| Piotroski | 6/9 | 8/9 | 6/9 | 6/9 |
| Valuation | 30/30 | 15/30 | 5/30 | 4/30 |
| Growth | 18/25 | 14/25 | 1/25 | 7/25 |
| Quality | 13/20 | 4/20 | 0/20 | 0/20 |
| Balance Sheet | 12/15 | 13/15 | 13/15 | 7/15 |
| Cash Flow | 0/10 | 2/10 | 2/10 | 2/10 |
| Price | ₹19.55 | ₹181.25 | ₹74.05 | ₹154 |
| P/E | 4.65 | 21.10 | 36.20 | — |
| P/B | 0.74 | 2.18 | 2.14 | 3.60 |
| ROE | 21.90% | 12.00% | 5.93% | -8.86% |
| ROCE | 27.20% | 15.10% | — | -2.18% |
| Debt / Equity | 0.14 | 0.03 | 0.00 | 0.80 |
| FCF Yield | — | — | 1.46% | — |
| Dividend Y | — | — | — | — |
| Altman Z | 4.22 | 8.82 | 7.27 | 2.73 |
| Promoter % | 68.96% | 66.34% | 61.71% | 73.11% |
| Mkt Cap (₹Cr) | 27.80 | 190.00 | 122.00 | 104.00 |
| Graham # | ₹50.2 | ₹126.51 | ₹39.79 | — |
| Fair PE | 42.0 | 42.0 | 7.9 | 30.3 |
| MoS % | +89.0% | +49.5% | -357.2% | — |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startMEDISTEP48
MADHAVBAUG73
NEPHROCARE41
MAITREYA118